CORSA study finds spike-specific blunted immune responses in lymphoma patients after SARS-CoV-2 vaccine - Top-Institutions - MDSpire

CORSA study finds spike-specific blunted immune responses in lymphoma patients after SARS-CoV-2 vaccine

  • By

  • Lucia Mazzotti

  • Gerardo Musuraca

  • Fabio Affaticati

  • Esther Bartholomeus

  • Diana Campillo-Davo

  • Carole Faghel

  • Chiara Zingaretti

  • Flavia Foca

  • Claudio Cerchione

  • Valentina Ancarani

  • Patricia Borges de Souza

  • Fabio Nicolini

  • Anna De Lucia

  • Anna Gaimari

  • Oriana Nanni

  • Vittorio Sambri

  • Giovanni Martinelli

  • Francesco Malaspina

  • Pieter Meysman

  • Eva Lion

  • Massimiliano Mazza

  • May 20, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Istituto Romagnolo per lo Studio dei Tumori “Dino Amadori”
    Istituto Romagnolo per lo Studio dei Tumori “Dino Amadori”

    Forlì, Emilia-Romagna

    Key Differentiators

    • Hematology
    • Oncology

  • #2

    The Royal Marsden Hospital NHS Foundation Trust
    The Royal Marsden Hospital NHS Foundation Trust

    London, England

    Key Differentiators

    • Hematology
    • Oncology

  • #3

    The Francis Crick Institute
    The Francis Crick Institute

    London, England

    Key Differentiators

    • Hematology
    • Immunology

  • #4

    Icahn School of Medicine at Mount Sinai
    Icahn School of Medicine at Mount Sinai

    New York, New York

    Key Differentiators

    • Hematology
    • Oncology

  • #5

    The Tisch Cancer Institute at Mount Sinai
    The Tisch Cancer Institute at Mount Sinai

    New York, New York

    Key Differentiators

    • Hematology
    • Oncology

Original Source(s)

CORSA study finds spike-specific blunted immune responses in lymphoma patients after SARS-CoV-2 vaccine

  • by Lucia Mazzotti, Gerardo Musuraca, Fabio Affaticati, Esther Bartholomeus, Diana Campillo-Davo, Carole Faghel, Chiara Zingaretti, Flavia Foca, Claudio Cerchione, Valentina Ancarani, Patricia Borges de Souza, Fabio Nicolini, Anna De Lucia, Anna Gaimari, Oriana Nanni, Vittorio Sambri, Giovanni Martinelli, Francesco Malaspina, Pieter Meysman, Eva Lion, Massimiliano Mazza

  • May 20, 2026

Related Content

ESR Essentials: imaging of lymphoma—practice recommendations by the European Society of Oncologic Imaging

The First NCI-Designated Comprehensive Cancer Center Using 3D Genomics Testing to Diagnose Lymphoma and Sarcoma—a True Game Changer

Diagnosing lymphoma and sarcoma can be extraordinarily complex, with more than 70 recognized subtypes of lymphoma and more than 100 distinct types of sarcoma. Many subtypes share similar features yet behave in dramatically different ways in standard testing, leaving oncologists with diagnostic quandaries and delays to treatment.

  • by

  • February 24, 2026

  • 4 min
High-dose chemotherapy with autologous haematopoietic stem cell transplantation in patients with isolated vitreoretinal lymphoma: a LOC network study